Item Type | Name |
Academic Article
|
Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.
|
Academic Article
|
Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.
|
Academic Article
|
Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
|
Academic Article
|
Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
|
Academic Article
|
Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
|
Academic Article
|
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
|
Academic Article
|
AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.
|
Academic Article
|
Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys.
|
Academic Article
|
Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: correlations between behavior and neurochemistry.
|
Academic Article
|
Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.
|
Academic Article
|
In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.
|
Academic Article
|
Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy.
|
Academic Article
|
Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
|
Academic Article
|
Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.
|
Academic Article
|
Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?
|
Academic Article
|
In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.
|
Academic Article
|
Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine.
|
Academic Article
|
Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.
|
Academic Article
|
Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.
|
Academic Article
|
The value of nonhuman primates in drug abuse research.
|
Academic Article
|
Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
|
Academic Article
|
Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
|
Concept
|
Ethanol
|
Concept
|
Amphetamines
|
Concept
|
Alkaloids
|
Concept
|
Analgesics, Opioid
|
Concept
|
Aporphines
|
Concept
|
Alcohol Deterrents
|
Concept
|
Cyclohexanols
|
Concept
|
Central Nervous System Agents
|
Concept
|
Cytochrome P-450 Enzyme System
|
Concept
|
Benzimidazoles
|
Concept
|
Drug Tolerance
|
Concept
|
Drug Evaluation, Preclinical
|
Concept
|
Aminopyridines
|
Concept
|
Adrenergic alpha-Antagonists
|
Concept
|
Adamantane
|
Concept
|
Central Nervous System Stimulants
|
Concept
|
Amphetamine
|
Concept
|
Appetite Depressants
|
Concept
|
Amides
|
Concept
|
Fluoxetine
|
Concept
|
Buprenorphine
|
Concept
|
Ethylamines
|
Concept
|
Benzodiazepines
|
Concept
|
Cannabis
|
Concept
|
Malate Dehydrogenase
|
Concept
|
Central Nervous System Depressants
|
Concept
|
Convulsants
|
Concept
|
Dopamine
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Carrier Proteins
|
Concept
|
p-Chloroamphetamine
|
Concept
|
Cannabinoids
|
Concept
|
Fluorine Radioisotopes
|
Concept
|
Cocaine
|
Concept
|
Cyclohexanones
|
Concept
|
Isoquinolines
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Fenclonine
|
Concept
|
Food
|
Concept
|
Naloxone
|
Concept
|
Tryptamines
|
Concept
|
Powders
|
Concept
|
Diazepam
|
Concept
|
Drug Synergism
|
Concept
|
Iodobenzenes
|
Concept
|
Morpholines
|
Concept
|
Ketanserin
|
Concept
|
Stereoisomerism
|
Concept
|
Tablets
|
Concept
|
Tritium
|
Concept
|
Drug Design
|
Concept
|
Phenethylamines
|
Concept
|
Nortropanes
|
Concept
|
Pentylenetetrazole
|
Concept
|
Alfentanil
|
Concept
|
Receptors, Opioid, kappa
|
Concept
|
Biogenic Monoamines
|
Concept
|
Capsules
|
Concept
|
Nitric Oxide
|
Concept
|
Quinuclidines
|
Concept
|
Morphine Derivatives
|
Concept
|
Trifluoroacetic Acid
|
Concept
|
GTP-Binding Proteins
|
Concept
|
alpha-Methyltyrosine
|
Concept
|
Recombinant Proteins
|
Concept
|
Neurotransmitter Uptake Inhibitors
|
Concept
|
Valine
|
Concept
|
Cytochrome P-450 CYP2D6
|
Concept
|
Vesicular Monoamine Transport Proteins
|
Concept
|
Single-Chain Antibodies
|
Concept
|
Platelet Aggregation Inhibitors
|
Concept
|
Serotonin 5-HT1 Receptor Agonists
|
Concept
|
Dopamine Agents
|
Concept
|
Hallucinogens
|
Concept
|
Glutathione
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
Concept
|
Drug Interactions
|
Concept
|
Fluorobenzenes
|
Concept
|
Narcotic Antagonists
|
Concept
|
Piperazines
|
Concept
|
Spiro Compounds
|
Concept
|
Receptors, sigma
|
Concept
|
Diterpenes, Clerodane
|
Concept
|
Prazosin
|
Concept
|
Propiophenones
|
Concept
|
Receptors, Opioid, delta
|
Concept
|
Adrenergic Uptake Inhibitors
|
Concept
|
Benzodioxoles
|
Concept
|
Serotonin Antagonists
|
Concept
|
Receptors, Dopamine D4
|
Concept
|
Serotonin 5-HT2 Receptor Agonists
|
Concept
|
Cannabinoid Receptor Agonists
|
Concept
|
Receptors, Adrenergic, alpha-1
|
Concept
|
Serotonin 5-HT2 Receptor Antagonists
|
Concept
|
Lysergic Acid Diethylamide
|
Concept
|
Receptor, Serotonin, 5-HT2C
|
Concept
|
Diterpenes
|
Concept
|
Dopamine Uptake Inhibitors
|
Concept
|
N-Methyl-3,4-methylenedioxyamphetamine
|
Concept
|
Racemases and Epimerases
|
Concept
|
Capsaicin
|
Concept
|
Indazoles
|
Concept
|
Glucuronidase
|
Concept
|
Methylamines
|
Concept
|
Naltrexone
|
Concept
|
Cyclohexylamines
|
Concept
|
Drug Antagonism
|
Concept
|
Fluoroacetates
|
Concept
|
Drug Inverse Agonism
|
Concept
|
Fentanyl
|
Concept
|
Ligands
|
Concept
|
Indoles
|
Concept
|
Imidazoles
|
Concept
|
Phthalimides
|
Concept
|
Immunoglobulin Fc Fragments
|
Concept
|
Receptors, Serotonin
|
Concept
|
Serotonin
|
Concept
|
Methamphetamine
|
Concept
|
Naphthalenes
|
Concept
|
Norepinephrine Plasma Membrane Transport Proteins
|
Concept
|
Serotonin Receptor Agonists
|
Concept
|
Psychotropic Drugs
|
Concept
|
Piperidines
|
Concept
|
Pyrazoles
|
Concept
|
Pyridines
|
Concept
|
Pentanones
|
Concept
|
Glucuronosyltransferase
|
Concept
|
Receptors, Cannabinoid
|
Concept
|
Receptor, Cannabinoid, CB1
|
Concept
|
Phencyclidine
|
Concept
|
Adrenergic Agents
|
Concept
|
Sulfonamides
|
Concept
|
Pyrrolidines
|
Concept
|
Uridine Diphosphate Glucuronic Acid
|
Concept
|
Reactive Oxygen Species
|
Concept
|
Benzeneacetamides
|
Concept
|
Tetrabenazine
|
Concept
|
Antipsychotic Agents
|
Concept
|
Tropanes
|
Concept
|
Receptors, Opioid, mu
|
Concept
|
Dopamine Plasma Membrane Transport Proteins
|
Concept
|
Drug Partial Agonism
|
Concept
|
Serotonin Agents
|
Concept
|
Glutamic Acid
|
Concept
|
Analgesics, Non-Narcotic
|
Concept
|
Cannabinoid Receptor Antagonists
|
Concept
|
Receptor, Serotonin, 5-HT2A
|
Concept
|
Receptor, Cannabinoid, CB2
|
Concept
|
Cytochrome P-450 CYP3A
|
Concept
|
Adrenergic alpha-1 Receptor Antagonists
|
Concept
|
Receptor, Serotonin, 5-HT1A
|
Concept
|
MicroRNAs
|
Concept
|
Oxalates
|
Concept
|
Receptors, Opioid
|
Concept
|
Designer Drugs
|
Concept
|
Benzoxazines
|
Academic Article
|
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to ?(9)-THC: mechanism underlying greater toxicity?
|
Academic Article
|
Methods of Behavior Analysis in Neuroscience
|
Academic Article
|
(Under Review) Forensic investigation of K2, Spice, and "bath salt" commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds
|
Academic Article
|
in Garcia-Rill E (ed) Translational Neuroscience: A Guide to a Successful Program
|
Academic Article
|
in Kuhar MJ and Madras BK (ed) The Effecs of Drug Abuse on the Human Nervous System
|
Academic Article
|
In Kuhar MJ and Madras BK (eds) The Effects of Drug Abuse on the Human Nervous System
|
Academic Article
|
?9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/'Spice' constituent JWH-018 in mice.
|
Academic Article
|
Baths salts, spice, and related designer drugs: the science behind the headlines.
|
Academic Article
|
Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice.
|
Academic Article
|
Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
|
Academic Article
|
Stereoselective Effects of Abused "Bath Salt" Constituent 3,4-Methylenedioxypyrovalerone in Mice: Drug Discrimination, Locomotor Activity, and Thermoregulation.
|
Academic Article
|
Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells.
|
Academic Article
|
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.
|
Academic Article
|
Synthetic Pot: Not Your Grandfather's Marijuana.
|
Academic Article
|
Phencyclidine-like in?vivo effects of methoxetamine in mice and rats.
|
Academic Article
|
Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development.
|
Academic Article
|
Cocaine-Like Discriminative Stimulus Effects of Mephedrone and Naphyrone in Mice.
|
Academic Article
|
Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.
|
Academic Article
|
Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems.
|
Academic Article
|
Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants.
|
Academic Article
|
Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-O-sulfate in rats: Drug discrimination and physical dependence.
|
Academic Article
|
Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.
|
Academic Article
|
Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice.
|
Grant
|
Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse
|
Grant
|
Effects of self-administered MDMA on brain and behavior in rhesus monkeys
|
Grant
|
INTRAVENOUS SELF ADMINISTRATION OF MDMA
|
Academic Article
|
Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22).
|
Academic Article
|
Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with ?9-Tetrahydrocannabinol and JWH-018.
|
Academic Article
|
In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation.
|
Academic Article
|
The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats.
|
Academic Article
|
Active vaccination reduces reinforcing effects of MDPV in male Sprague-Dawley rats trained to self-administer cocaine.
|
Grant
|
Evaluation of Hallucinogenic Substances using the Drug Discrimination Assay
|
Academic Article
|
Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats.
|
Academic Article
|
Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
|
Grant
|
Evaluation of enantiomer combinations of MDXX drugs in mouse models of autism
|
Academic Article
|
Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety.
|
Academic Article
|
Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations.
|
Academic Article
|
Phencyclidine-like abuse liability and psychosis-like neurocognitive effects of novel arylcyclohexylamine drugs of abuse in rodents.
|
Academic Article
|
Erratum to "Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety" [Drug Alcohol Depend. 250 (2023) 110917].
|